Identification of a Racially Dimorphic Variant in the Human Platelet PAR4 Thrombin Receptor Altering Platelet Function and Pharmacologic Inhibition

被引：0

作者：

Edelstein, Leonard C. ^{[1
]}

Simon, Lukas M. ^{[2
]}

Lindsay, Cory R. ^{[1
]}

Kong, Xiango ^{[1
]}

Montoya, Raul Teruel ^{[1
]}

Tourdot, Benjamin E. ^{[1
]}

Chen, Edward ^{[2
]}

Ma, Lin ^{[1
]}

Coughlin, Shaun R. ^{[3
]}

Nieman, Marvin T. ^{[4
]}

Holinstat, Michael ^{[1
]}

Shaw, Chad ^{[2
]}

Bray, Paul F. ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] UCSF, San Francisco, CA USA

[4] Case Western Reserve Univ, Cleveland, OH 44106 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Distinct roles for platelet GPIba, PAR4 and fibrin in regulating thrombin-dependent recruitment of leukocytes to sites of vascular injury
Kaplan, Z.
Alwis, I
Yuan, Y.
Ghasemzadeh, M.
Schoenwaelder, S. M.
Ruggeri, Z. M.
Jackson, S. P.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 185 - 186
[42] Improved Inhibition of Protease-Activated Receptor 4 (PAR4) with Function-Blocking Antibodies Provides Equivalent Antithrombotic Activity in the Face of the Hyper-Reactive Thr120 PAR4 Variant
French, Shauna L.
Thalmann, Claudia
Machlus, Kellie
Sleeman, Mark A.
Hamilton, Justin R.
BLOOD, 2017, 130
[43] Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)
Nantermet, PG
Barrow, JC
Lundell, GF
Pellicore, JM
Rittle, KE
Young, M
Freidinger, RM
Connolly, TM
Condra, C
Karczewski, J
Bednar, RA
Gaul, SL
Gould, RJ
Prendergast, K
Selnick, HG
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) : 319 - 323
[44] Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c
Leonard C Edelstein
Lukas M Simon
Raúl Teruel Montoya
Michael Holinstat
Edward S Chen
Angela Bergeron
Xianguo Kong
Srikanth Nagalla
Narla Mohandas
David E Cohen
Jing-fei Dong
Chad Shaw
Paul F Bray
Nature Medicine, 2013, 19 : 1609 - 1616
[45] Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c
Edelstein, Leonard C.
Simon, Lukas M.
Montoya, Raul Teruel
Holinstat, Michael
Chen, Edward S.
Bergeron, Angela
Kong, Xianguo
Nagalla, Srikanth
Mohandas, Narla
Cohen, David E.
Dong, Jing-fei
Shaw, Chad
Bray, Paul F.
NATURE MEDICINE, 2013, 19 (12) : 1609 - 1616
[46] The Common Racially Diverse Human PAR4 Variant Thr120 Causes Worse Outcomes in a Mouse Stroke Model Via Platelet-Mediated NET Formation: Prevention By P-Selectin Blockade
Denorme, Frederik
Portier, Irina
Stoller, Michelle L.
Tugolukova, Emilia A.
Montenont, Emilie
Bhatlekar, Seema
Cody, Mark
Rustad, John L.
Bray, Paul F.
Campbell, Robert A.
BLOOD, 2022, 140 : 5512 - 5513
[47] Activation of either PAR1 or PAR4 on human platelets can elicit expression of maximum platelet procoagulant activity.
Heger, CD
Mosley, CN
Tracy, PB
BLOOD, 2001, 98 (11) : 518A - 518A
[48] Non-peptidic small molecule antagonists of the human platelet thrombin receptor (PAR-1).
Nantermet, PG
Selnick, HG
Barrow, JC
Lundell, GF
Rittle, KE
Glass, KL
Young, M
Pellicore, JM
Ngo, PL
Freidinger, RM
Prendergast, K
Condra, C
Karczewski, J
Gould, R
Connolly, TM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U60 - U60
[49] PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation
Holinstat, Michael
Voss, Bryan
Bilodeau, Matthew L.
McLaughlin, Joseph N.
Cleator, John
Hamm, Heidi E.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (36) : 26665 - 26674
[50] Discovery of a non-peptide small molecule antagonist of the human platelet thrombin receptor (PAR-1).
Selnick, H
Nantermet, PG
Rittle, K
Lundell, GF
Barrow, JC
Glass, K
Young, M
Pellicore, JM
Ngo, PL
Freidinger, R
Prendergast, K
Gould, R
Condra, C
Karczewski, J
Connolly, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U540 - U540

← 1 2 3 4 5 →